EDXC stock led intraday gainers on PNK during market hours on 02 Mar 2026 after a sharp price jump and volume pickup. Endexx Corporation (EDXC) traded at $0.00050 USD with a reported intraday volume of 1,000,011.00 shares. The move followed a prior close of $0.00000 and registered a reported change of 49,900.00%, highlighting extreme volatility for this small‑cap healthcare name. We use Meyka AI’s real‑time tools to frame what drove the surge and the liquidity risks traders must track.

Price action and market context for EDXC stock

EDXC stock opened and traded at $0.00050 USD on PNK in United States market hours, with the session high and low both at that level. The reported volume was 1,000,011.00 versus an average volume of 1,110,858.00, producing a relative volume of 0.01. One clear claim: the move is volume‑driven and not sustained by broad institutional flows given the market cap of 171,556.00 USD and tiny float.

Fundamentals snapshot and valuation

Endexx Corporation operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic. Key metrics show EPS: 0.01 and PE: 0.03, while shares outstanding are 571,852,466.00. The company reports a year high of $0.00950 USD and a year low of $0.00030 USD. This paragraph’s claim: valuation ratios appear distorted by the extremely low share price and thin market cap, making standard multiples unreliable for fair value judgment.

Technical read and trading signals for EDXC stock

Technicals show mixed signals: RSI 42.96 suggests neutral momentum, while ADX 35.79 points to a strong short‑term trend. On‑balance volume (OBV) is negative at -33,674,855.00, reflecting prior selling pressure. One clear claim: short‑term traders should watch liquidity and bid depth on PNK because technical indicators can flip rapidly on tiny volume changes.

Meyka AI grade and model forecast for EDXC

Meyka AI rates EDXC with a score out of 100: 73.53 / 100 — Grade B+ — Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a near‑term reference target of $0.00200 USD versus the current price of $0.00050 USD, implying an estimated upside of 300.00%. Forecasts are model‑based projections and not guarantees. This paragraph’s claim: model outputs highlight potential upside but reflect high model risk on micro‑cap names.

Risks, liquidity and sector context

Endexx faces material liquidity and fundamental risks given the small market cap and thin trading. One claim: dirty bid/ask spreads and concentration among holders can cause extreme intraday swings. Sector context matters: the Healthcare drug manufacturers group has varied performance, and small CBD product players face regulatory and competitive pressure. Investors should weigh current ratio 0.04 and negative book value per share.

Catalysts and short‑term trading strategy for EDXC stock

Potential catalysts include corporate updates, distribution deals for cbdunlimited.com products, and regulatory clarifications for hemp‑derived offerings. One claim: active traders may scalp moves but should set strict stop losses and size positions small. For longer holders, watch quarterly earnings and revenue trends, plus retail demand metrics and inventory turnover improvements.

Final Thoughts

EDXC stock’s intraday surge on PNK on 02 Mar 2026 reflects a micro‑cap price move driven by low liquidity and concentrated trading. Current data show price USD 0.00050, volume 1,000,011.00, market cap 171,556.00 USD, and PE 0.03, but these metrics are fragile at such a low share price. Meyka AI’s forecast model projects a reference target of $0.00200 USD, an implied upside of 300.00% versus the current price, while acknowledging high model uncertainty. Traders should treat EDXC as high‑volatility, high‑risk exposure with possible short‑term gains but meaningful downside. Use small position sizes, tight risk controls, and monitor company updates on the Endexx website and social channels. For a conservative baseline, a nearer target of $0.00080 USD can serve as a lower‑case scenario, while the year high $0.00950 USD remains an extreme upside case. Forecasts are model‑based projections and not guarantees. Meyka AI provides this AI‑powered market analysis for context, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.